Skip to main content
Equasens logo

Equasens — Investor Relations & Filings

Ticker · EQS ISIN · FR0012882389 LEI · 96950066I7XVFGZI8L92 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 326 across all filing types
Latest filing 2017-07-20 M&A Activity
Country FR France
Listing PA EQS

About Equasens

https://equasens.com

Equasens is a company specializing in healthcare IT solutions for professionals and establishments. It develops and provides a range of products including professional software, electronic equipment, connected devices, and digital health solutions. The company's offerings cater to a diverse client base, including pharmacies, hospitals, nursing homes (EHPADs), home care services, and independent medical practitioners. The primary objective of its solutions is to improve the quality of patient care by facilitating the secure sharing of health data, enhancing communication between different care providers, and optimizing the coordination of care pathways across outpatient, hospital, and home care settings.

Recent filings

Filing Released Lang Actions
PHARMAGEST: major acquisition in the hospital information systems sect
M&A Activity Classification · 99% confidence The document is an announcement detailing the acquisition of a company (aXigate) by a subsidiary (MALTA INFORMATIQUE) of PHARMAGEST Group. It focuses on the strategic rationale, market positioning, operational synergies, and future growth opportunities resulting from this transaction. This type of corporate action announcement, which is not a standard periodic financial report (like 10-K or IR) or a simple management change, falls best under the category of a significant corporate event or transaction. Since there is no specific code for 'Acquisition Announcement,' and the content is a detailed press release about a major business development, it is most appropriately classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the acquisition involved significant new capital raising, but the primary focus here is the M&A activity itself. Given the options, 'M&A Activity' (TAR) is the most specific fit for an acquisition announcement, even if it's presented as a press release rather than a formal tender offer document. However, looking closely at the definitions, TAR is for 'merger proposals or takeover bids.' This is an acquisition announcement by the acquirer. Since it is a major corporate event announcement, and not a formal financial report, RNS is a strong fallback. Given the content is entirely about a major acquisition, TAR is the intended category for M&A news.
2017-07-20 English
PHARMAGEST : acquisition majeure sur le marché de l'inform
M&A Activity Classification · 99% confidence The document is a press release announcing a major acquisition: MALTA INFORMATIQUE (a subsidiary of PHARMAGEST) acquiring aXigate. The text details the strategic rationale, the capabilities of the acquired company (hospital information systems), and quotes from executives regarding the integration and future plans. This type of announcement, focusing on corporate structure changes, mergers, or acquisitions, directly corresponds to the M&A Activity category (TAR). It is not a standard financial report (10-K, IR, ER) or a general regulatory filing (RNS), but a specific corporate action announcement.
2017-07-18 French
PHARMAGEST INTERACTIVE : AGO du 27 juin 2017 - Résultats des votes
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and details the "RESULTAT DU VOTE DES RESOLUTIONS PRESENTEES A L'ASSEMBLEE GENERALE ORDINAIRE ANNUELLE DU 27 JUIN 2017" (Voting results of resolutions presented at the Annual General Meeting of June 27, 2017). This content directly corresponds to the official results of shareholder votes following an AGM. The definition for Declaration of Voting Results & Voting Rights Announcements (DVA) is: "Official results from shareholder votes at any general meeting (AGM or EGM).". Although it relates to an AGM, the specific content is the vote tally, making DVA the most precise classification over AGM-R (which is for presentations/materials) or RPA/RNS (which are for announcements of reports, whereas this is the result itself).
2017-07-05 French
PHARMAGEST INTERACTIVE : bilan semestriel 2017 du contrat de liquidité
Regulatory Filings Classification · 99% confidence The document is a press release dated July 5, 2017, titled "BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE GILBERT DUPONT" (Semi-annual balance sheet of the liquidity contract with the stock brokerage firm Gilbert Dupont). It reports the status of the liquidity account (number of shares and cash balance) as of June 30, 2017, and compares it to the December 31, 2016, balance. This document specifically details the status of a liquidity contract, which is a mechanism often related to share trading or market stabilization. It is not a full financial report (10-K or IR), an earnings release (ER), or a dividend notice (DIV). It is a specific regulatory/market activity update concerning share availability/trading support. Given the options, this type of specific, periodic update on market mechanisms or share activity fits best under Capital/Financing Update (CAP) or potentially a general Regulatory Filing (RNS). Since it details the status of a liquidity contract (related to share management/financing), CAP is a strong candidate, but it is also a very specific, non-standard filing. However, the core subject is the management of shares/liquidity, which aligns closely with capital structure activities or share transactions. Given the context of reporting on a liquidity contract balance, it is most closely related to share management/financing activities. If it were a report of the company buying back shares, it would be POS. Since it is reporting on the *liquidity contract* balance, it is a specific financing/capital management disclosure. I will classify it as Capital/Financing Update (CAP) as it relates to the management of shares held under a specific financial agreement, though RNS is a possibility if CAP is too narrow. Given the focus on the liquidity contract, CAP seems the most precise fit among the specific options provided for financial structure updates.
2017-07-05 French
PHARMAGEST INTERACTIVE : ON-LINE AVAILABILITY OF MEETING MATERIALS FOR
AGM Information Classification · 98% confidence The document is a press release titled "ON-LINE AVAILABILITY OF MEETING MATERIALS FOR THE ANNUAL ORDINARY GENERAL MEETING ON JUNE 27, 2017". It explicitly discusses the Annual Ordinary General Meeting (AGM), the agenda, draft resolutions, and where the meeting materials are available. This content directly relates to the AGM. Although it announces the availability of materials (which could suggest RPA), the core subject matter is the AGM itself, making AGM-R the most specific fit, as it covers presentations and materials shared during the AGM. Given the focus on the meeting details and materials availability, AGM-R is appropriate, though RPA is a close secondary consideration based on the 'Menu vs Meal' rule. However, since the document is about the AGM event and its associated documents, AGM-R is chosen as the primary classification.
2017-06-12 English
PHARMAGEST INTERACTIVE : AGO 27 juin 2017 - Avis de convocation
AGM Information Classification · 98% confidence The document is titled "ASSEMBLEE GENERALE ANNUELLE ORDINAIRE" and explicitly serves as an "Avis de convocation" (Notice of Meeting) for the Annual General Meeting (AGM) scheduled for June 27, 2017. It details the date, time, location, and mentions that the agenda and draft resolutions were previously published. This content directly relates to the preparation and announcement of the AGM. Therefore, the appropriate classification is AGM Information (AGM-R). The document length (2723 chars) is short, but the content is the notice itself, not just an announcement that a report is attached, making AGM-R more specific than RPA or RNS.
2017-06-12 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.